Thomas R. Insel

Last updated
Thomas Roland Insel [1]
Thomas Insel NIMH 2011.JPG
Born (1951-10-19) October 19, 1951 (age 68)
Alma mater Boston University (B.A.)
Boston University (M.D.)
Known forResearch on oxytocin and vasopressin and their impact on social behavior
Scientific career
Institutions National Institute of Mental Health
Emory University

Thomas Roland Insel (born October 19, 1951) is an American neuroscientist and psychiatrist who led the National Institute of Mental Health (NIMH) from 2002 until November 2015. [2] Prior to becoming Director of NIMH, he was the founding Director of the Center for Behavioral Neuroscience at Emory University in Atlanta, Georgia. [3] [4] He is best known for research on oxytocin and vasopressin, two peptide hormones implicated in complex social behaviors, such as parental care and attachment. [5] [6] He announced on Sept. 15, 2015, that he was resigning as the director of the NIMH to join the Life Science division of Google X (now Verily Life Sciences). [7] On May 8, 2017, CNBC reported that he had left Verily Life Sciences. [8] Insel is a Co-founder with Richard Klausner of a neuroscience company named "Mindstrong," [9] a Bay-area startup.


Early years

Born in Dayton, Ohio, Insel was the youngest of four sons. His father, H. Herbert Insel, was an ophthalmologist who moved the family from Ohio to Silver Spring, Maryland in 1960. There, the precocious Insel earned his Eagle Scout badge just after turning 13, began college courses at age 14 and left high school to enroll in the Boston University Combined Pre-Med- Medical Program, where he focused on English literature, at age 15. By age 17, having completed most of the requirements for his pre-medical degree and still below draft age, Insel began exploring the world. He hitch-hiked across Canada and through the West, married Deborah Silber soon after his 18th birthday, then traveled with her around the world, stopping to work at a TB clinic in Hong Kong and a mission hospital in Bihar, India.

From 1970-1974 Insel attended Boston University Medical School with plans to return to Asia working in tropical medicine. These plans changed with exposure to two prominent Boston neuroscientists: Walle Nauta at MIT and Norman Geschwind at Harvard Medical School. Following medical school, he trained in psychiatry at University California San Francisco (1976-1979) including a Jungian psychoanalysis and a first exposure to research with Irwin Feinberg.

Research career

Following clinical training, Insel joined the NIMH as a clinical fellow working with Dennis Murphy. In 1980 he began the first U.S. research project on the biology of adults with obsessive compulsive disorder (OCD), which was then largely treated with psychoanalysis. Following initial reports from Sweden, Insel was the first to demonstrate scientifically that a tricyclic antidepressant, clomipramine, was effective for treating OCD. This observation not only launched the neuropharmacological study of OCD, it suggested the importance of developing the SSRI class of antidepressants, which became a mainstay for treating both depression and OCD in the 1990s.

Following this foray into clinical research, Insel moved from the clinic into the laboratory to study the neurobiology of emotion. Beginning in the NIMH Laboratory of Brain Evolution and Behavior started by Paul Maclean in Poolesville, MD, his group developed some of the classic studies for investigating social behavior in animals, from ultrasonic vocalizations in rodent pups to social attachment in prairie voles to paternal care in marmosets. A major focus was oxytocin, known to support lactation and parturition, but shown in rats to be important for the initiation of maternal care by actions on brain receptors. Oxytocin and the related hormone vasopressin were also found to be critical for pair bonding in adult prairie voles. The Insel lab found that monogamous voles and non-monogamous voles (that did not pair bond) had brain receptors for oxytocin and vasopressin in different brain circuits, suggesting a mechanism for the evolution of monogamy in mammals.[ citation needed ]

In 1994 Insel was recruited to Emory University to direct the Yerkes Regional Primate Research Center, the nation's oldest and internationally one of the largest centers for research on monkeys and great apes. His tenure at Yerkes was marked by a focus on neurobiology and infectious disease, with a specific emphasis on development of an AIDS vaccine. This was also a period of considerable animal rights protests against Yerkes, with Insel and his family targeted by protesters opposed to invasive research with non-human primates.

In 1999 Insel resigned from Yerkes to lead a new $40 million National Science Foundation Science and Technology Center, the Center for Behavioral Neuroscience. This new program used behavioral neuroscience to develop a cross-institutional training and research effort for 7 colleges and universities in Atlanta, with a specific goal of increasing the number of African American undergraduate students participating in neuroscience research. This period was also a productive phase for social neuroscience research carried out at Emory. Larry Young, Zuoxin Wang, and Jim Winslow and several outstanding graduate students focused on the molecular biology, anatomy, and behavioral properties of oxytocin and vasopressin, providing critical evidence for the role of these neuropeptide systems in complex social behaviors. In his final years at Emory Insel led the team into studies of autism, starting a new NIH funded Autism Center to investigate oxytocin and vasopressin as potential treatments for this disorder of social behavior.

NIMH director

Insel's return to become the ninth director of NIMH in 2002 was unexpected, as he had little connection to academic psychiatry or psychology since his OCD research which ended almost twenty years before. At NIMH he quickly focused on serious mental illnesses, such as schizophrenia, bipolar illness, and major depressive disorder with a defining theme of these illnesses as disorders of brain circuits. Building on the genomics revolution, he created large repositories of DNA and funded many of the first large genotyping and sequencing efforts to identify risk genes. He established autism as a major area of focus for NIMH and led a large increase of NIH funding for autism research. Under his leadership, autism, as a developmental brain disorder, became a prototype for mental disorders, most of which also emerge during development. And during his tenure, NIMH became a leader in global mental health, working closely with the World Health Organization and the Global Alliance for Chronic Disease.


In May 2017, Dr. Insel joined Mindstrong, based in Palo Alto, California, as the startup's President and Co-Founder. [10]


Insel is a member of the National Academy of Medicine, National Academy of Sciences.[6] He has received the A.E. Bennett Award (1986), the Curt Richter Prize (1991), the Outstanding Service Award from the US Public Health Service (1993), the Sachar Prize (2007), the Outstanding Alumnus Award from Boston University (2009), the NAMI Outstanding Service Award (2009), the IPSEN Prize (2010), the Shorr Family Prize from the University of Arizona (2011), the Dr. Nathan Davis Award for Government Service from the American Medical Association (2013), the Jed Foundation Voice of Mental Health Award (2013), the American Psychiatric Nurses Association 2013 Scientific Partnership Award, the Brain & Behavior Research Foundation ‘Productive Lives’ Award (2014), the Child Mind Institute Distinguished Scientist Award (2014), and the Autism Science Foundation Distinguished Scientist Award (2015). In 2014 Insel also received an honorary degree from the University of Edinburgh, Scotland and in 2015 was commencement speaker for the School of Medicine at Emory University in Atlanta, Georgia.


In addition to over 200 published scientific articles or chapters, books by Insel include:

Related Research Articles

Vasopressin mammalian protein found in Homo sapiens

Vasopressin, also called antidiuretic hormone (ADH), arginine vasopressin (AVP) or argipressin, is a hormone synthesized as a peptide prohormone in neurons in the hypothalamus, and is converted to AVP. It then travels down the axon of that cell, which terminates in the posterior pituitary, and is released from vesicles into the circulation in response to extracellular fluid hypertonicity (hyperosmolality). AVP has two primary functions. First, it increases the amount of solute-free water reabsorbed back into the circulation from the filtrate in the kidney tubules of the nephrons. Second, AVP constricts arterioles, which increases peripheral vascular resistance and raises arterial blood pressure.

Oxytocin Peptide hormone and neuropeptide

Oxytocin (Oxt) is a peptide hormone and neuropeptide. It is normally produced in the hypothalamus and released by the posterior pituitary. It plays a role in social bonding, sexual reproduction, childbirth, and the period after childbirth. Oxytocin is released into the bloodstream as a hormone in response to stretching of the cervix and uterus during labor and with stimulation of the nipples from breastfeeding. This helps with birth, bonding with the baby, and milk production.

The National Institute of Mental Health (NIMH) is one of 27 institutes and centers that make up the National Institutes of Health (NIH). The NIH, in turn, is an agency of the United States Department of Health and Human Services and is the primary agency of the United States government responsible for biomedical and health-related research.

Paul D. MacLean American neuroscientist

Paul Donald MacLean was an American physician and neuroscientist who made significant contributions in the fields of physiology, psychiatry, and brain research through his work at Yale Medical School and the National Institute of Mental Health. MacLean's evolutionary triune brain theory proposed that the human brain was in reality three brains in one: the reptilian complex, the limbic system, and the neocortex.

The Yerkes National Primate Research Center located in Atlanta, Georgia, is owned by Emory University, is a center of biomedical and behavioral research, is dedicated to improving human and animal health, and is the oldest of seven National Primate Research Centers partially funded by the National Institutes of Health. It is known for its nationally and internationally recognized biomedical and behavioral studies with nonhuman primates by Emory University.

David Gil Amaral is a professor of psychiatry at the University of California, Davis, United States, and since 1998 has been the research director at the M.I.N.D. Institute, an affiliate of UC Davis, engaged in interdisciplinary research into the causes and treatment of autism and related neurodevelopmental disorders. Amaral joined the UC Davis faculty as a Professor in the Department of Psychiatry and the Center for Neuroscience and as an investigator at the California Regional Primate Research Center in 1991. Since 1995, he has been a professor of psychiatry in the UC Davis School of Medicine, with an appointment to the Center for Neuroscience.

Manuel Casanova American physician

Manuel F. Casanova is the SmartState Endowed Chair in Childhood Neurotherapeutics and a professor of Biomedical Sciences at the University of South Carolina School of Medicine Greenville. He is a former Gottfried and Gisela Kolb Endowed Chair in Outpatient Psychiatry and a Professor of Anatomical Sciences and Neurobiology at the University of Louisville.

George Koob American academic

George F. Koob, is a Professor and former Chair of the Committee on the Neurobiology of Addictive Disorders at The Scripps Research Institute and Adjunct Professor of Psychology, Psychiatry, and Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego. In 2014 he became the director of the National Institute on Alcohol Abuse and Alcoholism.

Trevor William Robbins CBE FRS FMedSci is a Professor of Cognitive neuroscience and former Head of the Department of Psychology at the University of Cambridge. Robbins has an international reputation in the fields of cognitive neuroscience, behavioural neuroscience and psychopharmacology.

Stephen Porges American psychologist

Stephen W. Porges is a "Distinguished University Scientist" at the Kinsey Institute, Indiana University Bloomington and professor in the department of psychiatry at the University of North Carolina in Chapel Hill in North Carolina. Prior to moving to North Carolina, Professor Porges directed the Brain-Body Center in the department of psychiatry at the University of Illinois at Chicago, where he also held appointments in the departments of psychology and bioEngineering, and worked as an adjunct in the department of neuroscience which he found suited him and it became his priority. Prior to joining the faculty at the University of Illinois at Chicago, Dr. Porges served as chair of the department of human development and director of the institute for child study. He is a former president of the Society for Psychophysiological Research and has been president of the Federation of Behavioral, Psychological and Cognitive Sciences, a consortium of societies representing approximately twenty-thousand biobehavioral scientists. He was a recipient of a National Institute of Mental Health Research Scientist Development award. He has chaired the National Institute of Child Health and Human Development, maternal and child health research committee and was a visiting scientist in the National Institute of Child Health and Human Development Laboratory of Comparative Ethology. He was awarded a patent on a methodology to describe neural regulation of the heart, and today is a lead neuroscientist with particular interests in cranial nerve responses as it relates to both animal and man in which there are specified responses that are physiological in the body. In 1994 he proposed the polyvagal theory providing insight into the mechanism mediating symptoms observed in the brain. The theory has stimulated research and treatments emphasizing the importance of physiological state and behavioral regulation.

C. Sue Carter Biologist and behavioral neurobiologist

C. Sue Carter is a biologist and behavioral neurobiologist. She is an internationally recognized expert in behavioral neuroendocrinology. In 2014 she was appointed Director of The Kinsey Institute and Rudy Professor of Biology at Indiana University. Carter was the first person to identify the physiological mechanisms responsible for social monogamy.

Richard Lewis Huganir is a Bloomberg Distinguished Professor in the Departments of Neuroscience and Psychological and Brain Sciences, Director of the Solomon H. Snyder Department of Neuroscience, and co-director of the Johns Hopkins Medicine Brain Science Institute at the Johns Hopkins University School of Medicine. He has joint appointments in the Department of Biological Chemistry and the Department of Pharmacology and Molecular Sciences in the Johns Hopkins School of Medicine.

Susan Swedo is a researcher in the field of pediatrics and neuropsychiatry, and since 1998 has been Chief of the Pediatrics & Developmental Neuroscience Branch at the US National Institute of Mental Health. In 1994, Swedo was lead author on a paper describing Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS), proposing a link between Group A streptococcal infection in children and some rapid-onset cases of obsessive-compulsive disorder (OCD) or tic disorders such as Tourette syndrome.

Gerald Fischbach American physician and neuroscientist

Gerald D. Fischbach is an American neuroscientist. He received his M.D. from the Weill Cornell Medical College of Cornell University in 1965 before beginning his research career at the National Institutes of Health in 1966, where his research focused on the mechanisms of neuromuscular junctions. After his tenure at the National Institutes of Health, Fischbach was a professor at Harvard University Medical School from 1972–1981 and 1990–1998 and the Washington University School of Medicine from 1981–1990. In 1998, he was named the director of the National Institute of Neurological Disorders and Stroke before becoming the Vice President and Dean of the Health and Biomedical Sciences, the Dean of the Faculty of Medicine, and the Dean of the Faculty of Health Sciences at Columbia University from 2001–2006. Gerald Fischbach currently serves as the scientific director overseeing the Simons Foundation Autism Research Initiative. Throughout Fischbach's career, much of his research has focused on the formation and function of the neuromuscular junction, which stemmed from his innovative use of cell culture to study synaptic mechanisms.

The Semel Institute for Neuroscience and Human Behavior is a research institute of the University of California Los Angeles (UCLA). It includes a number of centers, including the "Center for Neurobehavioral Genetics", which uses DNA sequencing, gene expression studies, bioinformatics, and the genetic manipulation of model organisms to understand brain and behavioral phenotypes.

Research Domain Criteria

The Research Domain Criteria (RDoC) project is an initiative being developed by US National Institute of Mental Health. In contrast to the Diagnostic and Statistical Manual of Mental Disorders maintained by the American Psychiatric Association, RDoC aims to be a biologically-valid framework for understanding mental disorders: "RDoC is an attempt to create a new kind of taxonomy for mental disorders by bringing the power of modern research approaches in genetics, neuroscience, and behavioral science to the problem of mental illness."

The development of an animal model of autism is one approach researchers use to study potential causes of autism. Given the complexity of autism and its etiology, researchers often focus only on single features of autism when using animal models.

Susan Amara neuroscientist

Susan G. Amara is an American professor of neuroscience and is the Scientific Director of the National Institute of Mental Health. Dr. Amara is an elected member of the National Academy of Sciences and a fellow of the American Association for the Advancement of Science. She is a Past-President of the Society for Neuroscience. Dr. Amara has a B.S. in Biological Sciences from Stanford University and a Ph.D. in Physiology and Pharmacology from the University of California, San Diego.

Charles L. Raison is an American psychiatrist and professor of psychiatry at the University of Wisconsin-Madison School of Medicine and Public Health as well as the Mary Sue and Mike Shannon Chair for Healthy Minds, Children & Families and Professor with the School of Human Ecology in Madison, Wisconsin.

Judith L. Rapoport American psychiatrist

Judith L. Rapoport is an American psychiatrist. She is the chief of the Child Psychiatry Branch at the National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH) in Bethesda, Maryland.


  1. "Medical Board of California Licensing Details for G 30484 - Insel, Thomas Roland". California Department of Consumer Affairs License Search Results. California DCA. Retrieved 30 Dec 2019.
  2. Insel, Thomas R. (29 October 2015). "Post by Former NIMH Director Thomas Insel: Farewell". Blog Posts by Thomas Insel (Blog). NIMH. Retrieved 13 May 2017.
  3. "Washington in Brief" . The Washington Post . 11 September 2002. p. A.05. Retrieved 13 May 2017.
  4. "Thomas R. Insel, M.D." University of Michigan Depression Center. University of Michigan. Archived from the original on 29 August 2004.
  5. "At NIMH, Outgrowing Jung Ideas; New Chief to Focus Studies On Genes and Neurobiology "The Washington Post Nov 13, 2002.
  6. "Archived copy". Archived from the original on 2009-06-20. Retrieved 2012-12-11.CS1 maint: archived copy as title (link)
  7. "Archived copy". Archived from the original on 2015-09-18. Retrieved 2015-09-15.CS1 maint: archived copy as title (link)
  9. "Former Director of the National Institute of Mental Health, Dr. Thomas Insel, Joins Mindstrong Health as President and Co-Founder". Market Wired. 11 May 2017. Retrieved 1 February 2018.
  10. "Former Director of the National Institute of Mental Health, Dr. Thomas Insel, Joins Mindstrong Health as President and Co-Founder". Market Wired. 11 May 2017. Retrieved 1 February 2018.